Clinical Trial Update: Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating nelfinavir mesylate in adults with liposarcoma (recurrent, metastatic, or unresectable soft tissue sarcoma) was terminated. Results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liposarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Nelfinavir mesylate (nelfinavir)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Adult Liposarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-02-23